Avantor Makes Multi-Year Investment in Hydration Capabilities for Biologics Production
Avantor plans to address rising global demand for biologics with their investment in hydration capabilities.
Avantor announced a multi-year investment into its global hydration capabilities on Aug. 31, 2021 that includes a recently completed expansion to its facility in Gliwice, Poland, as well as a multi-stage expansion of its facility in Aurora, Ohio, that is expected to be completed by mid-2022.
The facility investments in Gliwice and Aurora will add to Avantor’s existing water for injection-quality (WFI) buffer manufacturing capabilities. The new equipment will provide enhanced capabilities and capacity to formulate and fill WFI-based hydration solutions, according to a company press release.
"Buffer management is a key area where biopharma manufacturers can save time while reducing risk and costs,” said Ger Brophy, executive vice-president of Biopharma Production at Avantor, in the press release. “This recent investment in our global hydration offering allows us to strengthen our [C]GMP [current good manufacturing practices] chemical manufacturing in Europe and the United States."
Source: Avantor
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
